Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stenton, S. C.
Right arrow Articles by Hendrick, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stenton, S. C.
Right arrow Articles by Hendrick, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Occupational Medicine 1994;44:95-98
© 1994 Society of Occupational Medicine


case-report

Glutaraldehyde, asthma and work—a cautionary tale

S. C. Stenton*,, J. R. Beach*, J. H. Dennis*, N. P. Keaney{dagger} and D. J. Hendrick*

*Chest Unit and Regional Unit for Occupational Lung Disease, Newcastle General Hospital, University of Newcastle upon Tyne Newcastle upon Tyne, UK
{dagger}The Royal Infirmary Sunderland, UK

A 46-year-old endoscopy nurse developed symptoms suggestive of occupational asthma after seven years of exposure to glutaraldehyde. An initial inhalation challenge test at the endoscopy suite caused a very dramatic immediate fall in FEV1 from 3.6 to 1.5 litres. To further evaluate the case and establish a threshold for the response, a technique was devised to allow a series of double-blind inhalation challenges with activated glutaraldehyde vapour at exposure levels of 0.01–0.32 ppm. The results suggested marked dual asthmatic reactions following challenges with 0.032 ppm glutaraldehyde; however, similar ‘reactions’ were observed on control days. These were associated with an increase in airway responsiveness to methacholine, with the PD20FEV1 falling from >6400 µg to 135 µg. The interpretation of these results was potentially confounded by an intercurrent respiratory tract infection and by technically poor FEV1 recordings, so the challenge series was repeated three weeks later. The second series of double-blind inhalation challenges with carefully controlled exposures to glutaraldehyde (up to 0.32 ppm for 10 min) gave rise to no obvious asthmatic reactions, in marked contrast to the results of the unblinded workplace challenge. There was a slight increase in airway responsiveness, with the PD20FEV1 falling from >6400 µg to 1850 µg. These results illustrate the potential for misdiagnosis of occupational asthma when unblinded challenge tests are used and show that, even with sophisticated investigatory techniques, a clear-cut diagnostic result may be elusive.


Correspondence and reprint requests to: Dr S. C. Stenton, Chest Unit and Regional Unit for Occupational Lung Disease, Newcastle General Hospital, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 3PA, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
K. J. Klink and B. J. Meade
Dermal Exposure to 3-Amino-5-mercapto-1,2,4-triazole (AMT) Induces Sensitization and Airway Hyperreactivity in BALB/c Mice
Toxicol. Sci., September 1, 2003; 75(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
A Vyas, C A C Pickering, L A Oldham, H C Francis, A M Fletcher, T Merrett, and R M. Niven
Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff
Occup. Environ. Med., November 1, 2000; 57(11): 752 - 759.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.